It usually comes out at a bad moment. Dinner is cold, the kids are in bed, and your partner looks at the orange bottle on the counter and says it: "I'm done with pills." You want to be supportive. You also know that "done with pills" can sound a lot like "done with trying."

If you have heard that sentence, a survey we ran this summer suggests something reassuring. It is probably not a refusal of help. It is a preference that a lot of people share, paired with a gap in what they know.

Most people want the thing they have never heard of

Our survey quizzed 443 adults, scattered across ten Midwest states, on depression treatment. The numbers are final and validated, and the shape is clear.

We asked whether people knew what TMS was, and whether it mattered to them that a treatment did not rely on medication. A narrow majority, 51 percent, gave the same answer: TMS was unfamiliar, yet drug-free care mattered to them. Another 13 percent knew TMS and said the drug-free part mattered a lot. Combined, that comes to 64 percent who care about a route without medication. For the 156 husbands, wives, partners and relatives of people who served or who work as first responders, it was 72 percent.

Now look at the other side. Only 25 percent knew what TMS was at all. So the majority who want a drug-free option mostly do not know that one of the better-established ones exists.

That is the gap your partner may be standing in. "I'm done with pills" might really mean "I don't know there is anything else."

What that anything else looks like

Transcranial magnetic stimulation is a treatment in which a coil held near the scalp aims magnetic pulses at a brain region that helps govern mood. The patient is awake and sitting up. No medication and no anesthesia are part of the treatment. Its FDA clearance applies to adults whose major depression persists despite antidepressants. A typical course involves short sessions on weekdays for several weeks.

It is not the only drug-free path. Psychotherapy is more widely available, and electroconvulsive therapy is an established option for severe cases. But TMS is the one that most often surprises people, because so few have heard of it.

One distinction matters a lot here. You may have seen headlines about esketamine, sold as Spravato. It is a medication all the same, an FDA-approved spray for depression that other treatments have not relieved, administered with staff watching inside a certified clinic. A genuine option for some, perhaps, yet not drug-free. If your partner's line is "no more medication," esketamine does not answer it, and pitching it as an alternative to pills can erode trust. Should your partner stay open to medication, Brain Recovery Centers explains how Spravato treatment is supervised.

Your household may already be part of the pattern

Our survey found that the need is widespread. Asked about standard medication falling short on depression, anxiety, or PTSD, 72 percent said that had happened to them, to someone near them, or to both. For 22 percent the struggle belonged to someone close rather than themselves, and 13 percent reported both. Partners fall squarely in those groups.

If you are the one watching from a few feet away, you are not an unusual case. You are one of the most common people in this story.

Where your voice counts, and where it doesn't

Another question asked whose recommendation would carry the most weight in trying a new depression treatment. Friends and relatives placed second, at 18 percent. The runaway leader was the person's own doctor, at 74 percent.

That should shape how you help. You are not the one who will close the decision, and trying to argue your partner into a specific treatment usually backfires. What you can do is make sure the drug-free question actually reaches the person they trust most.

A few ways to do that without taking over:

The Midwest factor

Across the Midwest, distance is a real barrier. A treatment that asks for weekday visits over several weeks is much easier in a metro area than in a county where the nearest specialist is an hour away. In our survey, 43 percent picked "close to home" as one of their two top priorities when choosing a provider. If you live far from a city, part of your role may simply be helping map out whether a daily course is realistic, and whether the drive is one you can share.

Coverage is the other barrier. Choosing their two biggest priorities, 85 percent of respondents included insurance coverage. Many plans cover TMS after prior authorization, typically once several antidepressants have been tried. The list of medications your partner has already taken, with doses and dates, is often the most useful document you can help assemble.

What this is and isn't

This is not a case that TMS is right for your partner. It may not be. It is a case that "I'm done with pills" deserves a follow-up question, and that the question has a real answer more often than most families realize. Whether any treatment is appropriate is a decision for your partner and a clinician familiar with their medical past.

Should your partner tell you they want to die, or should you fear they will harm themselves, remember 988, where Suicide and Crisis Lifeline counselors handle calls and texts alike. You can reach out for them, beside them, or for yourself, and someone answers at every hour.

Methodology

Our publisher commissioned the study and footed the bill; the fieldwork ran on Pollfish's consumer panel and ended June 23, 2026. The 443 respondents, all 18 to 64, lived in Nebraska, Ohio, Iowa, Missouri, Oklahoma, Wisconsin, Kansas, Minnesota, Illinois, or Indiana. Component figures are rounded, and Pollfish's validation of the panel is complete, so these are the final numbers.